GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 107 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,298,000 | -8.5% | 200,000 | 0.0% | 0.00% | -25.0% |
| Q1 2019 | $1,418,000 | +45.9% | 200,000 | 0.0% | 0.00% | +33.3% |
| Q4 2018 | $972,000 | -33.9% | 200,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $1,470,000 | +15.2% | 200,000 | 0.0% | 0.00% | -25.0% |
| Q2 2018 | $1,276,000 | +17.3% | 200,000 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $1,088,000 | +30.5% | 200,000 | 0.0% | 0.00% | +50.0% |
| Q4 2017 | $834,000 | -56.7% | 200,000 | 0.0% | 0.00% | -66.7% |
| Q3 2017 | $1,926,000 | -18.6% | 200,000 | 0.0% | 0.01% | -14.3% |
| Q2 2017 | $2,366,000 | +59050.0% | 200,000 | +62991.5% | 0.01% | – |
| Q1 2017 | $4,000 | – | 317 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
| Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
| Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
| Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
| Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
| Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
| WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |